ADAM12 Activators
The class of chemicals termed ADAM12 Activators encompasses diverse compounds capable of modulating specific cellular pathways and processes, ultimately leading to the activation or potentiation of ADAM12. Among the selected chemicals, there exists a strategic array of activators targeting various intracellular signaling cascades. For instance, the inclusion of Bisindolylmaleimide I highlights the importance of the protein kinase C (PKC) pathway. Activated PKC can exert downstream effects, initiating a cascade of events that indirectly activate ADAM12 by influencing cellular processes associated with PKC signaling. Furthermore, Forskolin, a potent adenylate cyclase activator, contributes to the class by elevating intracellular cAMP levels. The subsequent activation of protein kinase A (PKA) can modulate signaling cascades interconnected with ADAM12, thus providing an indirect route for its activation. Notably, the paradoxical nature of LY294002, a phosphoinositide 3-kinase (PI3K) inhibitor, adds an intriguing dimension to the class. By disrupting negative feedback loops, LY294002 can activate downstream signaling pathways linked to ADAM12, exemplifying the indirect mechanisms by which this class of chemicals influences protein activation.
In addition, the class includes chemicals like SB203580, a p38 mitogen-activated protein kinase (MAPK) inhibitor, demonstrating the intricacies of indirect activation. Inhibition of p38 MAPK can perturb signaling cascades associated with ADAM12, indirectly promoting its activity. The inclusion of 9-cis-Retinoic Acid highlights the significance of retinoic acid receptors (RARs) in the class. Activation of RARs can modulate gene expression patterns, indirectly influencing pathways linked to ADAM12 activation. Collectively, the ADAM12 Activators class exemplifies a nuanced approach to modulating cellular processes. Each chemical contributes uniquely to the intricate web of signaling pathways associated with ADAM12, providing a foundation for understanding how these activators can orchestrate the activation of this specific target protein.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A potent protein kinase C (PKC) activator that can modulate the PKC signaling pathway. Activated PKC can influence downstream effectors, leading to alterations in cellular processes that indirectly activate ADAM12. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An adenylate cyclase activator that elevates intracellular cAMP levels. Increased cAMP can activate protein kinase A (PKA), subsequently influencing signaling cascades, potentially indirectly activating ADAM12 through PKA-mediated pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinase (PI3K) inhibitor that, paradoxically, can activate downstream signaling by disrupting negative feedback loops. This disruption may lead to the activation of pathways associated with ADAM12, indirectly promoting its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 mitogen-activated protein kinase (MAPK) inhibitor. Inhibition of p38 MAPK can affect signaling cascades linked to ADAM12, potentially leading to its indirect activation through modulation of pathways associated with p38 MAPK. | ||||||
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $71.00 $424.00 $3121.00 $5722.00 $148.00 | 10 | |
A retinoid that can modulate retinoic acid receptors (RARs). Activation of RARs can influence gene expression patterns, including genes involved in pathways related to ADAM12, thereby indirectly promoting its activation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A selective Rho-associated protein kinase (ROCK) inhibitor. Inhibition of ROCK can impact actin cytoskeleton dynamics and cellular motility, potentially indirectly activating ADAM12 through alterations in cellular processes linked to cytoskeletal changes. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
An actin polymerization inducer that can influence cytoskeletal dynamics. Changes in the actin cytoskeleton can affect cellular processes associated with ADAM12, potentially leading to its indirect activation through modulation of the cellular microenvironment. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
An AMP-activated protein kinase (AMPK) activator. AMPK activation can influence cellular energy homeostasis and downstream signaling pathways, potentially indirectly activating ADAM12 through the modulation of energy-sensitive cellular processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase (HDAC) inhibitor that can influence chromatin structure and gene expression. Changes in gene expression can impact pathways related to ADAM12, potentially leading to its indirect activation through modulation of epigenetic regulatory mechanisms. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An inhibitor of nuclear factor-kappa B (NF-κB) activation. Inhibition of NF-κB can alter the expression of genes involved in various signaling pathways, potentially indirectly activating ADAM12 through modulation of NF-κB-regulated pathways. | ||||||